[HTML][HTML] Identifying barriers and facilitators to successful implementation of computerized clinical decision support systems in hospitals: a NASSS framework-informed …

B Abell, S Naicker, D Rodwell, T Donovan, A Tariq… - Implementation …, 2023 - Springer
Background Successful implementation and utilization of Computerized Clinical Decision
Support Systems (CDSS) in hospitals is complex and challenging. Implementation science …

Lipoprotein apheresis: current recommendations for treating familial hypercholesterolemia and elevated lipoprotein (a)

MS Safarova, PM Moriarty - Current Atherosclerosis Reports, 2023 - Springer
Abstract Purpose of Review Familial hypercholesterolemia (FH) and hyperlipoproteinemia
(a) are relatively common disorders, posing a significant health burden due to increased risk …

Familial hypercholesterolaemia in 2020: a leading tier 1 genomic application

J Pang, DR Sullivan, T Brett, KM Kostner… - Heart, Lung and …, 2020 - Elsevier
Familial hypercholesterolaemia (FH) is caused by a major genetic defect in the low-density
lipoprotein (LDL) clearance pathway. Characterised by LDL-cholesterol elevation from birth …

[HTML][HTML] Barriers and facilitators to genetic testing for familial hypercholesterolemia in the United States: a review

RM Hendricks-Sturrup, KM Mazor, AC Sturm… - Journal of personalized …, 2019 - mdpi.com
Familial Hypercholesterolemia (FH) is an underdiagnosed condition in the United States
(US) and globally, affecting an estimated 1/250 individuals. It is a genetic risk factor for …

[HTML][HTML] Effect of clinical decision support for severe hypercholesterolemia on low-density lipoprotein cholesterol levels

H Bangash, S Saadatagah, M Naderian… - npj Digital …, 2024 - nature.com
Severe hypercholesterolemia/possible familial hypercholesterolemia (FH) is relatively
common but underdiagnosed and undertreated. We investigated whether implementing …

[HTML][HTML] An implementation science framework to develop a clinical decision support tool for familial hypercholesterolemia

H Bangash, L Pencille, JH Gundelach… - Journal of Personalized …, 2020 - mdpi.com
Electronic health record (EHR)-based clinical decision support (CDS) can address the low
awareness and undertreatment of familial hypercholesterolemia (FH), a disorder associated …

[HTML][HTML] Clinical decision support for familial hypercholesterolemia (CDS-FH): rationale and design of a cluster randomized trial in primary care

OP Lindell, LO Karlsson, S Nilsson, E Charitakis… - American Heart …, 2022 - Elsevier
Background: Familial hypercholesterolemia (FH) is an underdiagnosed and undertreated
genetic disorder with high risk of premature atherosclerotic cardiovascular disease and …

A scoping review of social and behavioral science research to translate genomic discoveries into population health impact

CG Allen, S Peterson, MJ Khoury… - Translational …, 2021 - academic.oup.com
Since the completion of the Human Genome Project, progress toward translating genomic
research discoveries to address population health issues has been limited. Several …

[HTML][HTML] Clinician perspectives on clinical decision support for familial hypercholesterolemia

H Bangash, O Elsekaily, S Saadatagah… - Journal of Personalized …, 2023 - mdpi.com
Familial Hypercholesterolemia (FH) is underdiagnosed in the United States. Clinical
decision support (CDS) could increase FH detection once implemented in clinical workflows …

Universal cholesterol screening among pediatric primary care providers within California and Minnesota: a qualitative assessment of barriers and facilitators

J Soukup, HA Zierhut, HE Ison - The Journal of Pediatrics, 2021 - Elsevier
Objective To assess current pediatric cholesterol screening practices, and attitudes, among
pediatric primary care providers (PCPs) via qualitative semistructured interviews designed to …